Targeting antiapoptotic Bcl-2 family members with AT-101 in pre-clinical models of aggressive lymphoma in combination with cyclophosphamide (C) and rituximab (R) produces a marked improvement in therapeutic efficacy Meeting Abstract
| Authors: | Paoluzzi, L.; Gonen, M.; Toner, L.; Smith, E.; Yang, D.; Holmund, J.; Sorensen, M.; O'connor, O. |
| Abstract Title: | Targeting antiapoptotic Bcl-2 family members with AT-101 in pre-clinical models of aggressive lymphoma in combination with cyclophosphamide (C) and rituximab (R) produces a marked improvement in therapeutic efficacy |
| Meeting Title: | 47th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 106 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2005 Dec 10-13 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2005-11-01 |
| Start Page: | 680A |
| End Page: | 681A |
| Language: | English |
| ACCESSION: | WOS:000233426004267 |
| PROVIDER: | wos |
| PUBMED: | 16342400 |
| DOI: | 10.1182/blood.V106.11.2420.2420 |
| Notes: | --- - Meeting Abstract: 2420 - 47th Annual Meeting of the American-Society-of-Hematology - DEC 10-13, 2005 - Atlanta, GA - Part 1 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
